GC-Rise Pharma of Beijing Raises $15 Million from OrbiMed

GC-Rise Pharma, a Beijing company that in-licenses women's and children's healthcare products for the China market, has closed a $15 million Series B financing from OrbiMed. Dr. Jonathan Wang, Co-Founder and Senior Managing Director of OrbiMed Asia, joined the GC-Rise Board of Directors. OrbiMed Asia, with offices in Shanghai and Mumbai, manages the first pan-Asia healthcare and life sciences private equity fund. More details.... Share this with colleagues: // //  
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.